Biochemistry, Endorphin

Excerpt

The endogenous opioid system comprises 4 families of neuropeptides: β-endorphins, enkephalins, dynorphins, and nociceptin. Each group derives from a distinct precursor protein and signals through opioid G-protein-coupled receptors (GPCRs). β-Endorphins, enkephalins, and dynorphins originate from the POMC, PENK, and PDYN genes, respectively, and primarily target the classical μ (MOR), δ (DOR), and κ (KOR) opioid receptors. These peptides share a conserved N-terminal tetrapeptide, Tyr-Gly-Gly-Phe, essential for receptor binding and activation. Nociceptin, derived from the PNOC gene, lacks this motif and binds a separate receptor, the nociceptin opioid receptor (NOP). This branch is functionally distinct and can modulate or counteract classical opioid signaling in pain, stress, and reward pathways.

β-Endorphins, enkephalins, dynorphins, and nociceptin modulate pain perception, emotional states, and reward pathways, providing a physiological basis for analgesia and mood regulation. Understanding the molecular biology, receptor pharmacology, and signal transduction of endogenous opioids is essential for clinicians, as it informs effective pain management and enhances insight into the pathophysiology of chronic pain and affective disorders.

Insights into opioid receptor function and signaling inform the therapeutic use of opioids such as morphine, clarifying mechanisms of analgesic efficacy as well as limitations including tolerance, dependence, and opioid-induced hyperalgesia (OIH). Recognition of the contribution of β-endorphins to phenomena such as exercise-induced euphoria underscores the broader neuromodulatory and hormonal roles of endogenous opioids.